Chapter 1 Executive Summary
Chapter 2 Radiopharmaceuticals Industry Analysis
2.1 Market Segmentation
2.2 Market Size and Growth Prospects
2.3 Drivers
2.4 Restraints
2.5 Key Opportunities Prioritized
2.6 Industry Analysis - Porter's
2.7 Market Share Analysis
Chapter 3 – Radiopharmaceutical Generators Market Analysis
3.1 W-188/Re-188 Generators
3.2 Mo-99/Tc-99m Generators
3.3 Sr-82/Rb-82 Generators
3.4 Sr-90/Y-90 Generators
3.5 Ge-68/Ga-67,68 Generators
Chapter 4 – Radiopharmaceuticals Application Market Analysis
4.1 Diagnostic Radiopharmaceuticals
4.1.1 SPECT (Single-Photon Emission Computed Tomography)
4.1.1.1 Yttrium (Y-90)
4.1.1.2 Technetium (Tc-99m)
4.1.1.3 Iodine (I-123)
4.1.1.4 Gallium (Ga-67)
4.1.1.5 Rhenium (Re-186)
4.1.1.6 Others
4.1.2 PET (Positron Emission Tomography)
4.1.2.1 Rubidium (Rb-82)
4.1.2.2 Fludeoxyglucose (18f-FDG)
4.1.2.3 Others
4.2 Therapeutic Radiopharmaceuticals
4.2.1 Oncology
4.2.1.1 Erbium-169 (169Er)
4.2.1.2 Iodine (I-131)
4.2.1.3 Lutetium-177 (Lu-177)
4.2.1.4 Yttrium (Y-90)
4.2.1.5 Strontium (Sr-89)
4.2.1.6 Samarium (Sm-153)
4.2.1.7 Others
4.2.2 Cardiology and Neurology
4.3 Theranostics
Chapter 5 – Radiopharmaceuticals End-User Application Market Analysis
5.1 Hospitals
5.2 Diagnostic Centers
Chapter 6 – Radiopharmaceuticals Market Regional Analysis
6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 RoW
Chapter 7 Competitive Landscape
7.1 Revenue Analysis
7.2 Product Benchmarking
7.3 Strategic Development
Chapter 8 Methodology & Scope
8.1 Research Methodology
8.2 Research Scope & Assumption
8.3 List of Data Sources